EPISODE 085
John Pavlidis, president and CEO of VytronUS, has built a strong resume leading and selling Medtech start-ups.
Now the self-described engineering “nerd” is leading VytronUS, a start-up combining the powers of imaging, ablation, and robotics to create a powerful new tool that can elevate the precision in the electrophysiology lab.
In this Medtech Talk Podcast, Pavlidis tells what lessons he learned jumping from a large company (Siemens) to serving as CEO of a small company.
He also explains the great potential for VytronUS, which is developing a catheter-based endocardial ablation platform based on Low-Intensity Collimated Ultrasound (LICU). LICU can produce high-resolution maps of cardiac anatomy and deliver ablative energy without touching the tissue.
Podcast Guest
John Pavlidis
President & CEO
Vytronus Inc
John joined VytronUS in early 2015 as the President and CEO. John has more than twenty-five years of medical device experience. Prior to VytronUS, John was President and CEO of Endoscopic Technologies, Inc. a leader in minimally invasive and endoscopic cardiac ablation, valve repair or replacement, and coronary bypass surgical technology. Endoscopic Technologies was acquired by AtriCure in late 2013. Previously, John served as President and CEO of R2 Technology Inc., the pioneer and leader in computer-aided detection of breast cancer, until Hologic Inc. acquired the company in 2006. Before joining R2 Technology, John was the President of the Ultrasound group at Siemens Healthcare for five years, where he led the acquisition and integration of Acuson Inc. and subsequent growth to $1 Billion revenue. John earned a B.S. in Biomedical Engineering from Rensselaer Polytechnic Institute and an M.S. in Engineering Sciences from the Thayer School of En gineering at Dartmouth College.
Meet Our Host
Geoff Pardo
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.